Background: Cardiogenic shock (CS) is the most life-threatening manifestation of acute
heart failure. Its complexity and high in-hospital mortality may justify the need for invasive …

Abstract Background The clinical CardShock risk score, including baseline lactate levels,
was recently shown to facilitate risk stratification in patients with cardiogenic shock (CS). As …

Background The use of percutaneous left ventricular assist devices in patients with acute
myocardial infarction complicated by cardiogenic shock (AMICS) is evolving. The aim of the …

Background Inflammatory response is an important feature of acute coronary syndromes
and myocardial infarction (MI). The prognostic value of proinflammatory cytokines in patients …

Cardiogenic shock (CS) is a complex and highly morbid entity conceptualised as a vicious
cycle of injury, cardiac and systemic decompensation, and further injury and …

Purpose To evaluate the association between the neutrophil-to-lymphocyte ratio (NLR) and
mortality across the cardiogenic shock (CS) severity spectrum, defined using the Society of …

Cardiogenic shock (CS) is characterized by peripheral vasoconstriction and critical end-
organ damage caused by inadequate cardiac output (CO) and oxygen delivery (DO2)[1]. In …

Abstract Rationale and Objective Acute myocardial infarction (AMI) results in the recruitment
of leukocytes to injured myocardium. Additionally, myocardium remote to the infarct zone …

Cardiogenic shock remains a highly lethal condition. Conventional therapy including
revascularization and mechanical circulatory support aims to improve cardiac output and …

In The Lancet Respiratory Medicine, Andrea Alemany and colleagues1 report the results of
CONV-ERT, a multicentre, double-blind, randomised controlled trial (RCT), administering …